Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 334

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial

Open access
Althabe, Fernando, Belizán, José M, McClure, Elizabeth M, Hemingway-Foday, Jennifer, Berrueta, Mabel, Mazzoni, Agustina, Ciganda, Alvaro, Goudar, Shivaprasad S, Kodkany, Bhalachandra S, Mahantshetti, Niranjana S, Dhaded, Sangappa M, Katageri, Geetanjali M, Metgud, Mrityunjay C, Joshi, Anjali M, Bellad, Mrutyunjaya B, Honnungar, Narayan V, Derman, Richard J, Saleem, Sarah, Pasha, Omrana, Ali, Sumera, Hasnain, Farid, Goldenberg, Robert L, Esamai, Fabian, Nyongesa, Paul, Ayunga, Silas, Liechty, Edward A, Garces, Ana L, Figueroa, Lester, Hambidge, K Michael, Krebs, Nancy F, Patel, Archana, Bhandarkar, Anjali, Waikar, Manjushri, Hibberd, Patricia L, Chomba, Elwyn, Carlo, Waldemar A, Mwiche, Angel, Chiwila, Melody, Manasyan, Albert, Pineda, Sayury, Meleth, Sreelatha, Thorsten, Vanessa, Stolka, Kristen, Wallace, Dennis D, Koso-Thomas, Marion, Jobe, Alan H, Buekens, Pierre M·2015·The Lancet

Abstract

Summary Background Antenatal corticosteroids for pregnant women at risk of preterm birth are among the most effective hospital-based interventions to reduce neonatal mortality. We aimed to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of antenatal corticosteroids at all levels of health care in low-income and middle-income countries. Methods In this 18-month, cluster-randomised trial, we randomly assigned (1:1) rural and semi-urban clusters within six countries (Argentina, Guatemala, India, Kenya, Pakistan, and Zambia) to standard care or a multifaceted intervention including components to improve identification of women at risk of preterm birth and to facilitate appropriate use of antenatal corticosteroids. The primary outcome was 28-day neonatal mortality among infants less than the 5th percentile for birthweight (a proxy for preterm birth) across the clusters. Use of antenatal corticosteroids and suspected maternal infection were additional main outcomes. This trial is registered with ClinicalTrials.gov, number NCT01084096. Findings The ACT trial took place between October, 2011, and March, 2014 (start dates varied by site). 51 intervention clusters with 47 394 livebirths (2520 [5%] less than 5th percentile for birthweight) and 50 control clusters with 50 743 livebirths (2258 [4%] less than 5th percentile) completed follow-up. 1052 (45%) of 2327 women in intervention clusters who delivered less-than-5th-percentile infants received antenatal corticosteroids, compared with 215 (10%) of 2062 in control clusters (p<0·0001). Among the less-than-5th-percentile infants, 28-day neonatal mortality was 225 per 1000 livebirths for the intervention group and 232 per 1000 livebirths for the control group (relative risk [RR] 0·96, 95% CI 0·87–1·06, p=0·65) and suspected maternal infection was reported in 236 (10%) of 2361 women in the intervention group and 133 (6%) of 2094 in the control group (odds ratio [OR] 1·67, 1·33–2·09, p<0·0001). Among the whole population, 28-day neonatal mortality was 27·4 per 1000 livebirths for the intervention group and 23·9 per 1000 livebirths for the control group (RR 1·12, 1·02–1·22, p=0·0127) and suspected maternal infection was reported in 1207 (3%) of 48 219 women in the intervention group and 867 (2%) of 51 523 in the control group (OR 1·45, 1·33–1·58, p<0·0001). Interpretation Despite increased use of antenatal corticosteroids in low-birthweight infants in the intervention groups, neonatal mortality did not decrease in this group, and increased in the population overall. For every 1000 women exposed to this strategy, an excess of 3·5 neonatal deaths occurred, and the risk of maternal infection seems to have been increased. Funding Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)61651-2

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 334

Metadata

Authors
Althabe, F., Belizán, J. M., McClure, E. M., Hemingway-Foday, J., Berrueta, M., Mazzoni, A., Ciganda, A., Goudar, S. S., Kodkany, B. S., Mahantshetti, N. S., Dhaded, S. M., Katageri, G. M., Metgud, M. C., Joshi, A. M., Bellad, M. B., Honnungar, N. V., Derman, R. J., Saleem, S., Pasha, O., Ali, S., Hasnain, F., Goldenberg, R. L., Esamai, F., Nyongesa, P., Ayunga, S., Liechty, E. A., Garces, A. L., Figueroa, L., Hambidge, K. M., Krebs, N. F., Patel, A., Bhandarkar, A., Waikar, M., Hibberd, P. L., Chomba, E., Carlo, W. A., Mwiche, A., Chiwila, M., Manasyan, A., Pineda, S., Meleth, S., Thorsten, V., Stolka, K., Wallace, D. D., Koso-Thomas, M., Jobe, A. H., & Buekens, P. M.
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-02
Volume
385
Issue
9968
Pages
629-639
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2158444099
Cited by
334
References
30
FWCI
26.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61651-2
The paper
Althabe, F., Belizán, J. M., McClure, E. M., Hemingway-Foday, J., Berrueta, M., Mazzoni, A., Ciganda, A., Goudar, S. S., Kodkany, B. S., Mahantshetti, N. S., Dhaded, S. M., Katageri, G. M., Metgud, M. C., Joshi, A. M., Bellad, M. B., Honnungar, N. V., Derman, R. J., Saleem, S., Pasha, O., . . . Buekens, P. M. (2015). A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. The Lancet. https://doi.org/10.1016/s0140-6736(14)61651-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.